1-(6-Amino-9H-purin-9-yl)-1-deoxy-N-ethyl-beta-D-ribofuranuronamid

Neca

HCID 448222CAS 35920-39-9

Grundinformationen

Standard-SMILES
CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O
InChIKey
JADDQZYHOWSFJD-FLNNQWSLSA-N
Summenformel
C12H16N6O4
Durchschnittliche Molmasse
308,29 g/mol
Monoisotopische Masse
308,12330299

Überblick

N-ethyl-5'-carboxamidoadenosine is a derivative of adenosine in which the 5'-hydroxymethyl group is replaced by an N-ethylcarboxamido group. It has a role as an antineoplastic agent, a vasodilator agent, an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor, an adenosine A1 receptor agonist and an adenosine A2A receptor agonist. It is a member of adenosines and a monocarboxylic acid amide. It is functionally related to an adenosine.

Namen und Bezeichner

Bevorzugter Name
Neca
IUPAC
(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide
Lokaler Name
1-(6-Amino-9H-purin-9-yl)-1-deoxy-N-ethyl-beta-D-ribofuranuronamid
Englischer Name
NECA
Summenformel
C12H16N6O4
Molmasse
308.29

Namen und Synonyme

NECAN-ethyl-5'-carboxamidoadenosine(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide3WC8SJ5ZLJCHEBI:73284RefChem:109229935920-39-95'-N-Ethylcarboxamidoadenosine5'-Ethylcarboxamido AdenosineAdenosine-5'-(N-ethylcarboxamide)N-Ethylcarboxamidoadenosine[3H]NECA
Weitere Namen anzeigen
D-NECA744-96765-21B-744-96NECA USP/EP/BPNECA, adenosine agonist5'-ETHYLCARBOXAMIDOADENOSINE5’-EthylcarboxamidoAdenosineAdenosine-5'-ethylcarboxamide
MFCD000691951-(6-Amino-9H-purin-9-yl)-1-deoxy-N-ethyl-beta-D-ribofuranuronamide(2S,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-N-ethyl-3,4-dihydroxytetrahydrofuran-2-carboxamideMLS000069759CHEMBL464859Adenosine-5-(N-ethylcarboxamide)AC-27392C12H16N6O4

Datenbank-Bezeichner

CAS
35920-39-9、78647-50-4
PubChem CID
448222
DTXSID
DTXSID801017234
ChEMBL
CHEMBL464859
ChEBI
CHEBI:73284
UNII
3WC8SJ5ZLJ
EC Number
636-060-5、636-863-0
Nikkaji
J260.378K

Eigenschaften

Berechnete Struktureigenschaften

XLogP
-0,7
Polarare Oberfläche (TPSA)
148 Ų
H-Brücken-Donoren
4
H-Brücken-Akzeptoren
8
Frei drehbare Bindungen
3
Schwere Atome
22

Experimentelle und physikochemische Eigenschaften

Solubility>46.2 [ug/mL] (The mean of the results at pH 7.4)

Physikochemische Eigenschaften

Schmelzpunkt
229 · 229-231°C
Dichte
1.87 · 1.87±0.1 g/cm3(Predicted)
storage temp.
2 · 2-8°C
Löslichkeit
45 % · 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.2 mg/mL Solutions may be stored for several days at 4°C.
pka
12.93 · 12.93±0.70(Predicted)
Aggregatzustand
powder

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 6 Einträge

Danger

H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 1 notifications to the ECHA C&L Inventory.

Danger

H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]

Gefahrenhinweise

Hazard Classes and Categories · 2 Einträge

Acute Tox. 2 (100%)

Acute Tox. 2 (100%)

Sicherheitsdaten

wgk
3
ridadr
UN 2811 6.1/PG 2
hs_code
29349990
RTECS-Nr.
VJ2232000
risk_code
28
hazard_code
T+

Chemie und Industrie

Anwendungen

VerwendenA potent adenosine receptor agonist. Inhibits platelet aggregation and is centrally active in vivo

Anbieter50 Anbieter

陕西缔都医药有限责任公司029-81124775 17791530730 · [email protected]
苏州道澜生物医药科技有限公司15952404857 · [email protected]
武汉英诺医药科技有限公司+86-027-59232304 15387063101 · [email protected]
成都超九八生物科技有限公司13348960310 13348960310 · [email protected]
武汉敬康恩生物医药科技有限公司13720134139 086-15871494362 13720134139 · [email protected]

Ergänzende Hinweise

DefinitionChEBI: A derivative of adenosine in which the 5'-hydroxymethyl group is replaced by an N-ethylcarboxamido group.

Zugehörige Reaktionen

5

Verknüpfte Notizen

Wird geladen…